[关于降低葡萄牙吸入器对环境的影响的建议:共识文件]
Luí S Campos1, Paula Rosa2, Pedro Carreiro Martins3
1Hospital CUF Tejo. Lisboa; Conselho Português para a Saúde e Ambiente. Lisboa. Portugal.
Acta medica portuguesa
|September 3, 2024
概括
本研究评估了葡萄牙吸入器对环境的影响,发现压力计量剂量吸入器对温室气体排放有显著的贡献. 提供了建议,以向更可持续的吸入器替代品过渡,减少生态足迹.
科学领域:
- 环境科学 环境科学
- 公共卫生 公共卫生
- 呼吸系统医学 呼吸系统医学
背景情况:
- 压力计量剂量吸入器 (pMDIs) 广泛用于呼吸系统疾病.
- 由于它们的推进剂,pMDIs对温室气体排放做出了重大贡献.
- 越来越需要解决医疗器械对环境的影响.
研究的目的:
- 评估葡萄牙吸入器对环境的影响.
- 评估医生对吸入器碳足迹的认识.
- 制定建议,以减少吸入器的生态足迹.
主要方法:
- 在葡萄牙计算pMDIs和干粉吸入器 (DPI) 的碳足迹.
- 估计处方医生对吸入器环境影响的认识.
- 制定一个包含建议的共识文件.
主要成果:
- 压力计量剂量吸入器对葡萄牙的温室气体排放有很大影响.
- 估计了医生对吸入器对环境影响的认识.
- 该研究为过渡到更可持续的吸入器选项提供了基础.
结论:
- 吸入器的生态足迹可以大大减少.
- 转向可持续的替代品对于环境健康至关重要.
- 需要共同努力来执行建议,并减少吸入器相关的排放.
相关概念视频
Inhaled Medications
244
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
244
Drugs Used in Lower Respiratory Disorders: Overview
362
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
362
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
188
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
188
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
228
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
228


